Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,089Revenue $M6.7Net Margin (%)-1,529.5Altman Z-Score9.2
Enterprise Value $M1,005EPS $-3.7Operating Margin %-1,533.5Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-1,529.5Higher ROA y-yY
Price/Book11.510-y EBITDA Growth Rate %-12.1Quick Ratio4.5Cash flow > EarningsY
Price/Sales1185-y EBITDA Growth Rate %-3.8Current Ratio4.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-97.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAXGeorge Soros 2012-06-30 Sold Out -0.03%$35.2 - $52.6
($42.76)
$ 28.36-34%Sold Out0
DVAXGeorge Soros 2012-03-31 Reduce-0.09%$32.8 - $50.3
($40.41)
$ 28.36-30%Reduce 62.50%37,500
DVAXGeorge Soros 2011-12-31 Buy 0.14%$18.2 - $33.3
($28.15)
$ 28.361%New holding100,000
DVAXGeorge Soros 2011-09-30 Sold Out -0.0026%$18.4 - $31.6
($24.39)
$ 28.3616%Sold Out0
DVAXGeorge Soros 2011-06-30 Buy 0.0026%$24.6 - $28.1
($26.35)
$ 28.368%New holding6,610
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVAX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Gray EddieCEO and Director 2014-08-14Buy2,500$14.990.34 view
KISNER DANIEL LDirector 2013-10-30Buy1,000$10.8162.59 view
ORONSKY ARNOLD LDirector 2013-10-30Buy18,605$10.8162.59 view
Phillips Peggy VDirector 2013-10-30Buy9,302$10.8162.59 view
Janssen RobertChief Medical Officer and VP 2013-07-09Sell0$0162.59 view
Novack David FSenior Vice President 2013-03-25Sell0$0162.59 view
COFFMAN ROBERTChief Scientific Officer & VP 2012-11-06Sell800$43.1-34.2 view
KESSEL MARKDirector 2012-10-16Sell600,000$47.3-40.04 view
COFFMAN ROBERTChief Scientific Officer & VP 2012-10-05Sell800$49.4-42.59 view
Lew JenniferVP, Finance & PAO 2012-09-14Sell1,875$45.3-37.4 view

Press Releases about DVAX :

Quarterly/Annual Reports about DVAX:

News about DVAX:

Articles On GuruFocus.com
Dynavax Reports Second Quarter 2015 Financial Results Aug 07 2015 
Dynavax Prices Public Offering of Common Stock Jul 22 2015 
Dynavax Announces Proposed Public Offering of Common Stock Jul 21 2015 
Dynavax Secures $40 Million Credit Facility With Hercules Technology Growth Capital Dec 29 2014 
William Blair’s Top BioPharmaceutical Stock Picks for Q1 2015 Dec 23 2014 
Dynavax Announces Webcast of R&D Day Dec 09 2014 
Dynavax and AstraZeneca to Advance TLR9 Agonist for Treatment of Asthma Into Phase 2a Clinical Study Dec 08 2014 
Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of Coll Nov 28 2014 
Dynavax Announces Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) Nov 10 2014 
Dynavax Reports Third Quarter 2014 Financial Results Nov 05 2014 

More From Other Websites
DYNAVAX TECHNOLOGIES CORP Financials Aug 20 2015
10-Q for Dynavax Technologies Corp. Aug 09 2015
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 07 2015
Dynavax Technologies reports 2Q loss Aug 07 2015
Dynavax Technologies reports 2Q loss Aug 07 2015
Dynavax Reports Second Quarter 2015 Financial Results Aug 07 2015
Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of... Jul 28 2015
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jul 22 2015
Dynavax Prices Public Offering of Common Stock Jul 22 2015
Dynavax Announces Proposed Public Offering of Common Stock Jul 21 2015
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other... Jul 09 2015
Trending Now: Dynavax Technologiesn Jul 09 2015
Dynavax Announces Third Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM)... Jul 09 2015
Dynavax Technologies (DVAX) in Focus: Stock Up 8.2% - Tale of the Tape Jul 07 2015
4 Big-Volume Stocks to Trade for Breakouts Jul 07 2015
RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech Jun 29 2015
Dynavax to Present at the William Blair 35th Annual Growth Stock Health Care Conference Jun 09 2015
Merck's Keytruda under Priority Review for Lung Cancer - Analyst Blog Jun 02 2015
DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 01 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK